Trade Summary

5 months ago, Ford Robert B, serving as COB, CEO at Abbott Laboratories (ABT), purchased 18,800 shares at $107.13 per share, for a total transaction value of $2,013,967.00. Following this transaction, Ford Robert B now holds 469,508 shares of ABT.

This purchase represents a 4.00% increase in Ford Robert B's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, January 23, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 26, 2026 at 8:02 AM ET, 3 days after the trade was made.

Abbott Laboratories operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.